This site requires Javascript.

Please enable Javascript before proceeding:

Firefox

  1. In the FireFox address bar, type about:config.
  2. Look for the javascript.enabled setting.
  3. Set it to true by right-clicking and pressing toggle.

Internet Explorer

  1. On the Tools menu, click Internet Options, then click the Security tab.
  2. Click the Internet Zone.
  3. If you do not have to customize your Internet security settings, click Default Level. Then do step 4.
  4. If you have to customize your Internet security settings, follow these steps:
    a. Click Custom Level.
    b. In the Security Settings - Internet Zone dialog box, click Enable for Active Scripting in the Scripting section.
  5. Click the Back button to return to the previous page, and then click the Refresh button to run scripts.

Chrome

  1. In the Chrome address bar, type chrome://settings/content/javascript.
  2. Adjust the toggle so that javascript is allowed.
  3. Close the Settings tab and Refresh the page.

 

Posters

Click on the PDF icon to view each individual poster.  Click on the comment icon to leave a question or comment for the poster presenter.  You can also reach out to the poster presenter in the chat on the day of the conference.

# PDF Comment Poster Title Primary Author Additional Authors
1 Implementing robotic pet therapy in continuing care settings: A scoping review of barriers and facilitators Brooklynn Fernandes J. Eng, A. Toohey, B. Lashewicz, M. Charbonneau, J. Holroyd-Leduc
2 Dancing towards better brain health: Virtual GERAS DANCE implementation for dementia care across Canada Patricia Hewston A. Papaioannou, C. Marr, A. Dashti, G. Hladysh, E. Coker, J. St Onge, C. Kennedy, G. Ioannidis
3 The Role of a Care Plan Manager in Supporting Family Caregivers in Dementia Care Smita Nayak
4 Risks and health-reinforcing factors for cognitive maintenance in men and women: a secondary analysis of the longitudinal SHARE data Yuliya Bodryzlova G. Moullec
5 Cognitive Impairments in Older Adults – Clinical Characteristics of Osler's Memory Clinic Shailesh Nadkarni M. Saldutto, J. Brar, S. Panchadcharadevan, F. Duah, S. Saha
6 Engaging hospitalized patients living with dementia in meaningful moments: An action research approach Sophia Matarazzo & Caroline Marr E. Coker, J. Sue, L. Mersereau, P. Hewston, C. Marr, A. Vehra, A. Papaioannou
7 Examining sex differences in health service use before and after diagnosis in a rural and remote memory clinic Julie Kosteniuk B. Acan Osman, D. Morgan, C. Karunanayake, M. E. O'Connell, A. Cammer, A. Kirk, M. Osman, A. Campbell, T. Levinton, J. Quail
8 Surgical trajectory of functional disability and depression in older adults with versus without suspected cognitive impairment: A longitudinal prospective cohort study Ellene Yan Y. Alhamdah, N. Butris, P. Kapoor, C. Tartaglia, D. He, F. Chung
10 Sex differences in caregivers' burden and perceptions of neuropsychiatric symptoms in Alzheimer's disease: A cross-sectional study Owen Skoda P. Desmarais, M. Houde, C. Vo-Dignard, D. Rioux
11 Identification of predictive factors for neuropsychiatric symptoms across neurodegenerative disorders: Baseline results of a longitudinal study Owen Skoda P. Desmarais, M. Houde, C. Vo-Dignard, D. Rioux
12 Comprehensive Clinical and Analytical Validations of Two Novel Plasma pTau217 Immunoassays in a Clinical Diagnostic Hans Frykman A. Mammel, A. Mousavi, P. Kumar, M. Encarnacion, K. Hallett, D. Biehl, P. Gil, S. Pflueger, G.-Y. R. Hsiung
13 Clinical decision points for two plasma p-tau217 laboratory developed tests in neuropathology confirmed samples Hans Frykman A. Mammel, A. Mousavi, P. Kumar, M. Encarnacion, K. Hallett, I. Mackenzie, V. Hirsch-Reinshagen, D. Biehl, P. Gil, S. Pflueger, G.-Y. R. Hsiung
14 The effects of non-modifiable risk factors of Alzheimer’s disease (AD) on plasma pTau217 Concentrations Hans Frykman A. Mammel, A. Mousavi, P. Kumar, M. Encarnacion, K. Hallett, D. Biehl, P. Gil, S. Pflueger, G.-Y. R. Hsiung
15 Comparison of diagnostic performance of CSF biomarkers with plasma pTau217 concentrations in predicting clinically diagnosed Alzheimer’s disease Hans Frykman A. Mammel, A. Mousavi, P. Kumar, M. Encarnacion, K. Hallett, D. Biehl, P. Gil, S. Pflueger, G.-Y. R. Hsiung
16 The Performance of Two Plasma tau-217 Immunoassays in Distinguishing Alzheimer's Disease Pathology at Different Stages Hans Frykman A. Mammel, A. Mousavi, P. Kumar, M. Encarnacion, K. Hallett, I. Mackenzie, V. Hirsch-Reinshagen, D. Biehl, P. Gil, S. Pflueger, G.-Y. R. Hsiung
17 A Head-to-Head Comparison of Clinical Performance of Two Novel Plasma pTau217 Immunoassays for Detecting Alzheimer’s pathology Hans Frykman A. Mammel, A. Mousavi, P. Kumar, M. Encarnacion, K. Hallett, I. Mackenzie, V. Hirsch-Reinshagen, D. Biehl, P. Gil, S. Pflueger, G.-Y. R. Hsiung
18 Awareness of Actions to Reduce Dementia Risk Among First Nations People in File Hills Qu'Appelle Tribal Council: A Review of the Brain Health PRO Platform Letebrhan Ferrow N. Akan, J. A. Furlano, N. Anderson, W. Wittich, J. D. Walker, S. Belleville, L. Middleton, A. Froehlich, G. Boehme, C. Ashdoehonk, B. Peigan, N. Jack, R.a McKay, M. Crant, R. Bellegarde
19 Longitudinal associations between vascular risk factors and mild behavioral impairment Ibadat Warring D. Guan, M. Ghahremani, E. E. Smith, Zahinoor Ismail
20 The interplay of social contact, apathy, and loneliness: Associations with cognitive symptoms in Canadian adults Jasper F.E. Crockford D. X. Guan, D. Vellone, E. E. Smith, Z. Ismail
21 Investigating traumatic brain injury as a moderator in the relationship between cortical thickness and volume and mild behavioral impairment Gurshaan Sidhu D. Guan, M. Ghahremani, Z. Ismail
22 Association of Mild Behavioural Impairment with plasma inflammatory biomarkers in individuals with Mild Cognitive Impairment Sabika Azhar D. Guan, M. Ghahremani, Z. Ismail
23 Barriers to Clinical Care in Frontotemporal Dementia and Related Disorders: Patients and Caregivers' Journey in the Canadian Healthcare System Alexandrine Martineau M. Conant, P. Desmarais
24 Canadian Healthcare Providers' Perceptions on Accessibility of Diagnostic Tools and Specialized Resources for Frontotemporal Dementia and Related Disorders Alexandrine Martineau M. Conant, P. Desmarais
25 An Education Intervention to Improve Attitudes Towards Dementia and Sense of Competency in Dementia Care Among Nurses in Acute Care Settings: A Mixed Methods Study Winnie Lam A. Wang, R. Sears
26 Integrating Virtual Reality Reminiscence Therapy into Dementia Care: An Exploratory Study Winnie Sun W. Sun, A. Quevedo, S.Elgazzar
27 An Index to Quantify Burden of Modifiable Risk for Dementia at the Community-Level in New Brunswick Sandra Magalhaes P. Singh, S. Cookson, P. Jarrett, K. Faig, C. McGibbon
28 A Dementia Registry for Canada: A community-driven, made-in-Ontario solution Adam Morrison C. Stergiou-Dayment, C. Siu, C. Studzinski
29 Unraveling 5 Major Mysteries of Dementia: Insights from the Melanin Theory Stacie Z. Berg J. Berg
30 Implementation of novel biomarkers in a real world memory clinic in Canada- Initial findings from the bioMIND study Jaspreet Bhangu M. Borrie, S. Best, K. Van Der Ploeg, A. Patwardhan, J. Wells
32 Clinical utility of the Montreal Cognitive assessment (MoCA) in Long COVID (PCS) associated brain fog Angela G. Juby C. M.J. Davis
33 Identifying endophenotypes of APOE-e4 to unravel clinicopathological heterogeneity and mixed neuropathologies across the Lewy body disease spectrum: current advances and emerging opportunities Usman Saeed M. Masellis
Register
Returning Registrant

Event Date & Time

October 18, 2024
9 am - 5 pm Eastern Daylight Time (EST)

Event Location

Virtual, Zoom Events

Information & Assistance

Conference Services
conferences@uhn.ca